Skip to main content

and
  1. No Access

    Article

    Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy

    Met is a receptor tyrosine kinase that promotes cancer progression. In addition, Met has been implicated in resistance of tumors to various targeted therapies such as epidermal growth factor receptor inhibitor...

    B Kim, S Wang, J M Lee, Y Jeong, T Ahn, D-S Son, H W Park, H-s Yoo, Y-J Song in Oncogene (2015)